Guy on Rocks: North of the border with White Cliff Minerals
With election fever heating up in the US, host Guy Le Page takes us north of the border to Nunavut and the Northwest Territories in Canada.
Stockhead
Guy on Rocks: Peregrine Gold
Guy Le Page goes into post-Trump metals markets before looking at Capricorn-adjacent Peregrine Gold as his stock of the week.
Prospect posts 500,000t of copper metal in maiden resource
Prospect Resources has significantly derisked the Mumbezhi copper project in Zambia with its initial resource, one of the largest deposits held by an ASX junior.
Guy on Rocks: Cyclone Metals
Guy Le Page looks at Cyclone Metals in the wake of a MoU with minerals titan Vale for development of its Iron Bear project.
More Stories
EcoGraf enjoys biggest gain in over four years
EcoGraf’s focus turns towards financing after receiving the grant of a Special Mining Licence at the Epanko graphite project.
Imricor advances its FDA approval hopes
Imricor has achieved another key milestone with the second module for premarket approval of its devices submitted to the US FDA.
ASX health stocks fall
Morgans analyst Scott Power said this ‘particular reporting season has been one of the worst for a long time’ for ASX healthcare sector
Road to 2025: Compumedics
Fraser Palamara looks at Compumedics, a company that diagnoses sleeping disorders, monitors neurological afflictions and sophisticated brain analysis.
ASX erases 2025 gains; energy stocks slump
The ASX has taken another dive after Trump’s tariff news. Aussie miners and tech stocks have been hit, while Suncorp swirls lower amid cyclone worries.
ASX falls almost 4pc in February
Australia’s S&P/ASX 200 fell 4% in February as global geopolitical and economic uncertainties rattled markets.
Envirosuite, Spacetalk led in a tricky Feb
February saw Trump’s tariffs shake up the markets, with ASX tech taking a hit, led by WiseTech’s sharp drop.
Neuren shares should be worth at least twice as much, analysts say
Healthcare analysts believe that shares in rare neurological share play Neuren Pharmaceuticals are well undervalued after a sustained sell-off.
BTR confirms potential future resource upgrade at Sandstone Hub
BTR is squaring up for a resource upgrade after drilling confirmed continuity of high-grade gold at Lord Nelson
Palladium positioned for rebound
Rusty Delroy returns for Counter Cycle and this time he tells us why he sees big opportunities in the sold-off platinum group metals market.
Original URL: https://www.ntnews.com.au/business/stockhead/page/20